{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T01:26:38Z","timestamp":1770427598039,"version":"3.49.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[1999,6,25]],"date-time":"1999-06-25T00:00:00Z","timestamp":930268800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[1999,7]]},"DOI":"10.1038\/sj.bjc.6690575","type":"journal-article","created":{"date-parts":[[2003,4,29]],"date-time":"2003-04-29T16:09:35Z","timestamp":1051632575000},"page":"1644-1647","source":"Crossref","is-referenced-by-count":52,"title":["Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation"],"prefix":"10.1038","volume":"80","author":[{"given":"U","family":"Menon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Talaat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A R","family":"Jeyarajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A N","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N D","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S J","family":"Skates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Sibley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D H","family":"Oram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I J","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,6,25]]},"reference":[{"key":"BF6690575_CR1","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/bmj.299.6712.1363","volume":"299","author":"S Campbell","year":"1989","unstructured":"Campbell, S., Bhan, V., Royston, P., Whitehead, M. I. & Collins, W. P. (1989). Transabdominal ultrasound screening for early ovarian cancer. Br Med J 299: 1363\u20131367.","journal-title":"Br Med J"},{"key":"BF6690575_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1006\/gyno.1995.1181","volume":"58","author":"A Gadducci","year":"1995","unstructured":"Gadducci, A., Zola, P., Landoni, F., Maggino, T., Sartori, E., Bergamino, T. & Cristofani, R. (1995a). Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study. Gynecol Oncol 58: 42","journal-title":"Gynecol Oncol"},{"key":"BF6690575_CR3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0140-6736(88)90351-0","volume":"1","author":"IJ Jacobs","year":"1988","unstructured":"Jacobs, I. J., Stabile, I., Bridges, J., Kemsley, P., Reynolds, C., Grudzinskas, J. & Oram, D. (1988). Multimodal approach to screening for ovarian cancer. Lancet 1: 268\u2013271.","journal-title":"Lancet"},{"key":"BF6690575_CR4","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","volume":"97","author":"IJ Jacobs","year":"1990","unstructured":"Jacobs, I. J., Oram, D., Fairbanks, J., Turner, J., Frost, C. & Grudzinskas, J. G. (1990). A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol 97: 922\u2013929.","journal-title":"Br J Obstet Gynaecol"},{"key":"BF6690575_CR5","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1136\/bmj.306.6884.1030","volume":"306","author":"IJ Jacobs","year":"1993","unstructured":"Jacobs, I. J., Davies, A. P., Bridges, J., Stabile, I., Fay, T., Lower, A., Grudzinskas, J. G. & Oram, D. (1993). Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. Br Med J 306: 1030\u20131034.","journal-title":"Br Med J"},{"key":"BF6690575_CR6","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1136\/bmj.313.7069.1355","volume":"313","author":"IJ Jacobs","year":"1996","unstructured":"Jacobs, I. J., Skates, S., Davies, A. P., Woolas, R. P., Jeyerajah, A., Weidemann, P., Sibley, K. & Oram, D. H. (1996). Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study. Br Med J 313: 1355\u20131358.","journal-title":"Br Med J"},{"key":"BF6690575_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0029-7844(95)00126-C","volume":"86","author":"F Nagele","year":"1995","unstructured":"Nagele, F., Petru, E., Medl, M., Kainz, C., Graf, A. H. & Sevelda, P. (1995). Preoperative CA 125: an independent prognostic factor in patients with stage I epithelial ovarian cancer. Obstet Gynecol 86: 259\u2013264.","journal-title":"Obstet Gynecol"},{"key":"BF6690575_CR8","unstructured":"Rothman, K. J. (1986). Modern Epidemiology, pp. 218. Little Brown: Boston"},{"key":"BF6690575_CR9","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1200\/JCO.1996.14.5.1545","volume":"14","author":"GJ Rustin","year":"1996","unstructured":"Rustin, G. J., Nelstrop, A. E., McClean, P., Brady, M. F., McGuire, W. P., Hoskins, W. J., Mitchell, H. & Lambert, H. E. (1996a). Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125. J Clin Oncol 14: 1545\u20131551.","journal-title":"J Clin Oncol"},{"key":"BF6690575_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/oxfordjournals.annonc.a010602","volume":"7","author":"GJ Rustin","year":"1996","unstructured":"Rustin, G. J., Nelstrop, A. E., Tuxen, M. K. & Lambert, H. E. (1996b). Defining progression of ovarian carcinoma during follow-up according to CA125: a North Thames Ovary Group Study. Ann Oncol 7: 361\u2013364.","journal-title":"Ann Oncol"},{"key":"BF6690575_CR11","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1471-0528.1996.tb09882.x","volume":"103","author":"S Tingulstad","year":"1996","unstructured":"Tingulstad, S., Hagen, B., Skjeldestad, F. E., Onsrud, M., Kiserud, T., Halvorsen, T. & Nustad, K. (1996). Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol 103: 826\u2013831.","journal-title":"Br J Obstet Gynaecol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6690575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690575","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:54:35Z","timestamp":1684414475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6690575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6,25]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1999,7]]}},"alternative-id":["BF6690575"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6690575","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,6,25]]}}}